Lipoprotein (Lp)(a) concentrations were measured in eight patients with nephrotic syndrome in the age range of 8 to 69 yrs. Mean(± SE) levels of serum Lp(a) were elevated in the nephrotic patients compared to controls (76.5 ± 19.7 vs 18.6 ± 0.9 mg/dl, p <0.001). After treatment with prednisolone, Lp(a) concentrations were decreased from 85.2 ±21.6 to 42.2 ± 14.0 mg/dl. During the treatment, serum total cholesterol showed a negative correlation with serumalbuminconcentration. However, no correlation wasnoted betweenLp(a) and serum albumin concentration. There were no significant correlations between Lp(a) and other lipoprotein lipid and apolipoprotein levels. It was concluded that hyperLp(a) aemia may be an independent risk factor in the development of premature atherosclerosis in patients with nephrotic syndrome.
(IHD). Although the pathogenesis of arteriosclerotic changes in patients with nephrotic syndrome remains to be elucidated, hyperlipoproteinemia associated with nephrotic syndrome and corticosteroid therapy may, in part, play an important role in the development of premature atherosclerosis.
The authors recently reported a case of nephrotic syndrome presenting hyperLp(a)aemia accompanied by myocardial infarction and cerebral infarction in a case of systemic lupus erythematosus (1) . In the present study, serum Lp(a) concentrations were determined in order to investigate any abnormalities of lipoprotein metabolism in patients with nephrotic syndrome.
SUBJECTS AND METHODS
Subjects were twelve previously untreated patients with nephrotic syndrome (8 males and 4 females, average age 31±13 yrs), who have been under treatment and hospitalized in our hospital. Healthy normal subjects were used for comparison. Renal biopsy specimens were determined by light microscopy and a fluorescent antibody method (Table 1) . Fasting blood samples were drawn for serum lipoprotein analysis. According to the method of Havel et al (2) * Focal GN, focal glomerulonephritis electrophoresis was performed using 3.6% polyacrylamide gels as described by Narayan et al (3) . Theconcentrations of serumapolipoprotein were measured by single radial immunodiffusion using plates obtained from Daiichi Kagaku Co., Tokyo, Japan (4). Quantitation of Lp(a) was determined using a single radial immunodiffusion method in which 1% agarose (PH 8.6, Agarose immunodiffusion tablets, Bio-rad, Richmond, Virginia) containing 1% Lp(a) antiserum was used (5) . The courses of 8 cases could be followed up with the collection of blood samples being performed after an improvementof serum protein level and the disappearance of urine protein or its diminution to less than 0.5 g/day. Informed concent was obtained from all individuals prior to beginning the study. Table 2 shows TC and TG values of lipoprotein for all healthy normal subjects and untreated patients with nephrotic syndrome, before and after treatment. TC and TG in whole serum, VLDL,IDL, LDL and HDLbefore treatment showed significantly higher values than the controls, as was the same as TC in whole serum, LDLand HDLand as TG in whole serum, IDL, LDL and HDLafter treatment. As far as the nephrotic syndromeas a whole was concerned, Lp(a) showed significantly higher values, 76.5 ± 19.7 mg/dl compared with 18.6±0.9 mg/dl, for healthy normal subjects (mean ± SE) (Fig. 1) . In the comparison of between before and after treatment with prednisolone, TC was significantly decreased. ApoB also showed a decreasing tendency. HDL-Cremained unchanged. Lp(a) concentrations were decreased from 85.2 ± 26.1 to 42.2 ± 14.0 mg/dl but this decrease was not statistically significant (Fig. 2) . Figure 3 shows the relationship of serum lipid levels before and after treatment; TC and serum protein showed a significant negative correlation, but neither correlation was noted among TG, HDL-C, apo B and Lp(a) inherited as an autosomal dominant trait (6) . Many studies have been conducted on the relationship of Lp(a) with ischemic heart disease from 1970 (7) (8) (9) (10) (11) (12) (13) . Through protein sequencing and CDNA cloning, McLean et al reported that apo(a) is very similar to human plasminogen, the precursor of the proteolytic enzyme plasmin which dissolves fibrin clots (14). Recent studies have suggested that the competition of Lp(a) and plasminogen for cellular According to Kohtoku et al, the disappearance of the broad mid-band pattern after their remission, which disc electrophoresis revealed at a high frequency in patients with nephrotic syndrome, suggests the involvement, in its appearance, of lowering of serum albumin and the leakage of protein and other substances into the urine (17).
RESULTS
Here, Lp(a) was noted as a single sharp band between VLDLand LDLby disc electrophoresis. In addition, a part of the above band had a high possibility of being Lp(a). In summary, hyperLp(a)aemia, which occurs at a high incidence in untreated patients with nephrotic syndromewas suggested to be an independent risk factor in arteriosclerotic heart disease in patients with nephrotic syndrome. 
